As expected, the values of IC50 showed that overexpression of SLC27A5 sensitizes HCC cells to sorafenib (Fig. 2G), and knockout of SLC27A5 attenuates the inhibitory effect of sorafenib (Fig. 2H). This evidence concerns the gene SLC27A5 and hepatocellular carcinoma.